Literature DB >> 15488676

Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.

A R Mohammed1, N Weston, A G A Coombes, M Fitzgerald, Y Perrie.   

Abstract

Liposomes due to their biphasic characteristic and diversity in design, composition and construction, offer a dynamic and adaptable technology for enhancing drug solubility. Starting with equimolar egg-phosphatidylcholine (PC)/cholesterol liposomes, the influence of the liposomal composition and surface charge on the incorporation and retention of a model poorly water soluble drug, ibuprofen was investigated. Both the incorporation and the release of ibuprofen were influenced by the lipid composition of the multi-lamellar vesicles (MLV) with inclusion of the long alkyl chain lipid (dilignoceroyl phosphatidylcholine (C24PC)) resulting in enhanced ibuprofen incorporation efficiency and retention. The cholesterol content of the liposome bilayer was also shown to influence ibuprofen incorporation with maximum ibuprofen incorporation efficiency achieved when 4 micromol of cholesterol was present in the MLV formulation. Addition of anionic lipid dicetylphosphate (DCP) reduced ibuprofen drug loading presumably due to electrostatic repulsive forces between the carboxyl group of ibuprofen and the anionic head-group of DCP. In contrast, the addition of 2 micromol of the cationic lipid stearylamine (SA) to the liposome formulation (PC:Chol - 16 micromol:4 micromol) increased ibuprofen incorporation efficiency by approximately 8%. However further increases of the SA content to 4 micromol and above reduced incorporation by almost 50% compared to liposome formulations excluding the cationic lipid. Environmental scanning electron microscopy (ESEM) was used to dynamically follow the changes in liposome morphology during dehydration to provide an alternative assay of liposome stability. ESEM analysis clearly demonstrated that ibuprofen incorporation improved the stability of PC:Chol liposomes as evidenced by an increased resistance to coalescence during dehydration. These finding suggest a positive interaction between amphiphilic ibuprofen molecules and the bilayer structure of the liposome. copyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15488676     DOI: 10.1016/j.ijpharm.2004.07.010

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  57 in total

1.  Design of liposomal colloidal systems for ocular delivery of ciprofloxacin.

Authors:  Ehab I Taha; Magda H El-Anazi; Ibrahim M El-Bagory; Mohsen A Bayomi
Journal:  Saudi Pharm J       Date:  2013-08-08       Impact factor: 4.330

2.  Development of nanovesicular systems for dermal imiquimod delivery: physicochemical characterization and in vitro/in vivo evaluation.

Authors:  Man Ma; Jinping Wang; Fang Guo; Mingzhu Lei; Fengping Tan; Nan Li
Journal:  J Mater Sci Mater Med       Date:  2015-05-20       Impact factor: 3.896

3.  Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers.

Authors:  Sureewan Duangjit; Praneet Opanasopit; Theerasak Rojanarata; Tanasait Ngawhirunpat
Journal:  AAPS PharmSciTech       Date:  2012-12-14       Impact factor: 3.246

Review 4.  Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.

Authors:  Mayuri Narvekar; Hui Yi Xue; June Young Eoh; Ho Lun Wong
Journal:  AAPS PharmSciTech       Date:  2014-04-02       Impact factor: 3.246

5.  Effects of nanoliposomal and pegylated nanoliposomal artemisinin in treatment of breast cancer.

Authors:  Neda Dadgar; Maedeh Koohi Moftakhari Esfahani; Sepideh Torabi; Seyed Ebrahim Alavi; Azim Akbarzadeh
Journal:  Indian J Clin Biochem       Date:  2013-10-01

6.  CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation.

Authors:  Aftab Ullah; Kaikai Wang; Pengkai Wu; David Oupicky; Minjie Sun
Journal:  Int J Nanomedicine       Date:  2019-04-26

Review 7.  Improved delivery of poorly soluble compounds using nanoparticle technology: a review.

Authors:  Sandeep Kalepu; Vijaykumar Nekkanti
Journal:  Drug Deliv Transl Res       Date:  2016-06       Impact factor: 4.617

8.  Influence of cholesterol on liposome stability and on in vitro drug release.

Authors:  Maria-Lucia Briuglia; Chiara Rotella; Amber McFarlane; Dimitrios A Lamprou
Journal:  Drug Deliv Transl Res       Date:  2015-06       Impact factor: 4.617

Review 9.  Liposomes in tissue engineering and regenerative medicine.

Authors:  Nelson Monteiro; Albino Martins; Rui L Reis; Nuno M Neves
Journal:  J R Soc Interface       Date:  2014-12-06       Impact factor: 4.118

10.  PLGA/liposome hybrid nanoparticles for short-chain ceramide delivery.

Authors:  Peng Zou; Stephan T Stern; Duxin Sun
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.